Evofem Biosciences Q3 2021 Earnings Preview

  • Evofem Biosciences (NASDAQ:EVFM) is scheduled to announce Q3 earnings results on Monday, November 15th, after market close.
  • The consensus EPS Estimate is -$0.29 (+21.6% Y/Y) and the consensus Revenue Estimate is $3.39M (+1110.7% Y/Y).
  • Over the last 3 months,…

Click here to view the original article.